Article Text
Abstract
A report by the Nuffield Council on Bioethics, contrary to the Declaration of Helsinki, permits most important research initiatives in developing countries.
The Ethics of Research Related to Health Care in Developing Countries by the Nuffield Council on Bioethics makes a number of innovative recommendations that depart from codes such as the Declaration of Helsinki. It recommends that standards of care might be relativised to the standard of that nation. It recommends that very good reasons need to be given for not giving post-trial access to medications but recognises that there may be justifiable instances of this. It is the view of the authors that these and other recommendations of the report are sensible pieces of advice given the complexities of the developing world.
- Helsinki
- developing world
- ethical review
- research
- standard of care
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- A comparison of justice frameworks for international research
- It is time to revise the international Good Clinical Practices guidelines: recommendations from non-commercial North–South collaborative trials
- Ethical issues raised by cluster randomised trials conducted in low-resource settings: identifying gaps in the Ottawa Statement through an analysis of the PURE Malawi trial
- Systematic scoping review of cluster randomised trials conducted exclusively in low-income and middle-income countries between 2017 and 2022
- HIV prevention research and global inequality: steps towards improved standards of care*
- A new look at international research ethics
- The standard of care debate: the Declaration of Helsinki versus the international consensus opinion
- The Ethics of Clinical Research in Developing Countries
- Tougher guidelines needed for research in developing countries
- Point-of-care testing and treatment of sexually transmitted and genital infections during pregnancy in Papua New Guinea (WANTAIM trial): protocol for an economic evaluation alongside a cluster-randomised trial